Evaluation methodologies

Milestone 5: Planning

Student’s Name

Institution

Course

Instructor

Date

Milestone 5: Planning

Guided by this need, there is a program plan designed to improve the care delivery to patients with sickle cell disease (SCD). This plan focuses on the issues related to physicians’ knowledge, availability of certain kinds of doctors, and policies to eliminate stereotypes. This is necessary to ensure that SCD patients receive high-quality, equitable care, irrespective of any stigma or bias (Badawy, 2021). This planning section defines the goal, principles and regulatory concerns, budgetary provisions, expected results, and time frame on how to achieve the project.

Objectives

The program aims to improve the quality of sickle cell disease (SCD) by increasing physician awareness, access to SCD specialists, and policy initiatives to eradicate prejudicial beliefs. Objectives include:

1. Physician Education: Create a program to educate healthcare practitioners about SCD and set a goal for 80% of physicians involved in the program's first year (Badawy, 2021).

2. Access to Care: Collaborate with specialized centers and promote the creation of new units in medical facilities, increasing the number of patients by 50% in two years.

3. Policy Development: Formulate policies to eliminate stereotypes in SCD across various institutions, with the goal of implementing three policy changes within the next 18 months (Badawy, 2021).

Ethical and Legal Considerations

The program will respect the four principles of ethical decision-making: autonomy, non-maleficence, beneficence, and justice. A key value is autonomy; therefore, patients’ self-determination will be honored in all engagements. The principles of nonmaleficence and beneficence shall inform all efforts to treat and care for the patient, so that the patient is neither harmed nor left worse off. Justice will be tackled by promoting equal treatment rights and combating prejudice in other areas, such as health facilities (Munung et al., 2023). Legal issues would include adhering to legal requirements for operating a healthcare institution and the patients' rights to privacy, as evidenced by the Health Insurance Portability and Accountability Act (HIPAA).

Financial Considerations

The program's financial costs include materials and literature, training, employees, and equipment upgrades. Revenue will be obtained from hospital working capital, government grants, and contracts with non-profit organizations that are looking to address the issue of SCD. Financial plans will be prepared to allow for better fund expenditure and utilization (Munung et al., 2023). The potential benefits include better health for SCD patients, including reduced readmission rates and higher patient satisfaction, which may impact reimbursement and funding.

Anticipated Issues-Related Outcomes

The program expects several risks, such as the potential for healthcare staff to resist change, minimal budget at the start of the project, and policy adoption hiccups. To enhance implementation, plan development entails measures like stakeholder engagement to ensure commitment, phased implementation schedules to cater for financial limitations, and sustained advocacy to increase the pace of policy shifts (Munung et al., 2023). The expected benefits are better clinical status for SCD patients, decreased prejudice in healthcare facilities, and higher awareness among healthcare workers—all of which would ultimately raise the quality of care for SCD patients.

Timeline

The timeline for achieving the program objectives is as follows:

Phase 1 (Months 1-6): Administer pre-tests to measure current physicians’ knowledge and patient access barriers. Initiate the development of instructional resources and first drafts of policies.

Phase 2 (Months 7–12): Provide the educational program and initiate specific training. Start collaborations with focus care centers.

Phase 3 (Months 13-18): Assess the effectiveness of the educational program and make necessary modifications. Propose and consolidate the policy.

Phase 4 (Months 19-24): Evaluate the effects of the program on the quality of care and overall patient satisfaction. Reporting of the results and prospects for future enhancements.

Conclusion

In conclusion, the ambulatory care improvement strategy for SCD outlined here seeks to fill perceived research-, physician awareness-, specialized care-, and policy-based gaps. The importance of ethical principles, fiscal responsibility, and identification of potential issues of concern in this campaign is geared toward enhancing the quality of the care and health of patients with sickle cell disease.

References

Badawy, S. M. (2021). Clinical trial considerations in sickle cell disease: Patient-reported outcomes, data elements, and the stakeholder engagement framework. Hematology, 2021(1), 196–205. https://doi.org/10.1182/hematology.2021000252

Munung, N. S., Nnodu, O. E., Moru, P. O., Kalu, A. A., Impouma, B., Treadwell, M. J., & Wonkam, A. (2023). Looking ahead: Ethical and social challenges of somatic gene therapy for sickle cell disease in Africa. Gene Therapy, 31(5–6), 202–208. https://doi.org/10.1038/s41434-023-00429-7

Milestone Three: Resource Allocation for Enhancing Sickle Cell Disease Care Delivery

Student’s Name

Institutional Affiliation

Course

Instructor’s Name

Date

Qualified Staff

Essential to the successful implementation of the program is the employment of a competent healthcare team. These comprise contracting specialized haematologists, nurse practitioners who deal with chronic illnesses, and culturally competent social workers. Such specialists will be instrumental in catering for the extensive management that patients with Sickle Cell Disease need. Furthermore, training programs for staff members already working in the health facilities will be required to make them understand Sickle Cell Disease, increase their ability to diagnose it and fight stigmatized illnesses in society. Training shall be accomplished through academic collaboration between renowned academic institutions and through organized seminars to be facilitated by experts in order to update healthcare providers on current discoveries in the management of Sickle Cell Disease (Jonathan et al., 2022).

Information Management Systems

There is a need to ensure a strong information management system is put in place to capture outcomes, monitor the patients, oversee the processes of treatment and coordinate care among the staff. Lastly, an EHR system of patient information, laboratory results, and treatment plans will be helpful in platting the care and ensuring that all the carer has access to the patient information to enable speedy quality care (Miller et al., 2020). Information management systems will also have functionality for telepoint, which means that patients from villages and other territories with low density will be able to receive help from doctors and specialists without constant visits to hospitals. The system has to operate in accordance with the HIPAA standards of patient privacy and security. The first intervention will require consulting with information technology experts in order to intervene in the processes of configuring the electronic health record system appropriately for Sickle Cell Disease treatment.

Technology and Equipment

Modern equipment and tools are required in the treatment of complications of Sickle Cell Disease. This entails the use of diagnostic equipment like image appliances to detect effects like organ damage and also the use of pump appliances for intravenous injections. Further, there will be a need to have portable diagnostic devices in order to conduct remote monitoring as well as tele consults. Purchasing these technologies will require entering into a contract with suppliers of medical equipment to get the most efficient equipment at an affordable price that meets the required quality of patient care (Jonathan et al., 2022). These resources shall be deployed depending on the criticality of patients and the established need during the assessment phase.

Financial Resources

It is, therefore, clear that the implementation of this program will need a lot of funding. Such funds are needed for the recruitment of competent employees, purchase and servicing of medical equipment, establishing the information management and setting up the communities' awareness programs. Hospital funding will be through a direct hospital appropriation, supplemented by specific government health department grants and probably also by specific grants from bodies concerned with Sickle cell disease research and care treatment non-profit organizations. A clear budget will be prepared, which will be used to identify the various costs that will incurred and used to see whether or not the resources have been used appropriately. This will also encompass the cooking of clean accounts and financial audits carried out on a regular basis.

Plan for Accessing and Assigning Resources

The resource allocation plan will be organized in a way that will ensure it achieves its goals and objectives to the optimum without wastage. Resource acquisition and Resource allocation will be coordinated in line with the project timeline so as to ensure that all the required resources are availed at the time they are required. Overworking will be avoided by developing staff schedules that will ensure that they provide care during the day and night without getting exhausted, while technology will be implemented gradually to ensure that it will work as planned. The funding proposal is contingent on the priority of each activity, which means that activities like staff training and implementation of the electronic health record will be funded right from the start (Jonathan et al., 2022). In order to safeguard the sustainability of the project, a logical contingency fund will be created within the premise to address contingences as they will be inevitable.

References